Lifecore Biomedical to Present at Stephens Annual Investment Conference
Lifecore Biomedical (NASDAQ: LFCR) has announced its participation in the upcoming Stephens Annual Investment Conference, scheduled for November 19-21, 2024, in Nashville, Tennessee. The company's president and CEO, Paul Josephs, will be featured in a fireside chat on Tuesday, November 19, 2024, at 2:00 p.m. Central time at the Grand Hyatt Nashville. Additionally, Lifecore management will be available for one-on-one meetings during the conference.
Lifecore Biomedical (NASDAQ: LFCR) ha annunciato la sua partecipazione alla prossima Conferenza Annuale sugli Investimenti di Stephens, prevista per il 19-21 novembre 2024, a Nashville, Tennessee. Il presidente e CEO dell'azienda, Paul Josephs, sarà presente in una conversazione informale martedì 19 novembre 2024, alle 14:00, ora centrale, al Grand Hyatt di Nashville. Inoltre, il management di Lifecore sarà disponibile per incontri individuali durante la conferenza.
Lifecore Biomedical (NASDAQ: LFCR) ha anunciado su participación en la próxima Conferencia Anual de Inversiones de Stephens, programada para el 19-21 de noviembre de 2024 en Nashville, Tennessee. El presidente y CEO de la compañía, Paul Josephs, será parte de una charla a fuego lento el martes 19 de noviembre de 2024 a las 2:00 p.m., hora central, en el Grand Hyatt de Nashville. Además, la gerencia de Lifecore estará disponible para reuniones uno a uno durante la conferencia.
Lifecore Biomedical (NASDAQ: LFCR)는 2024년 11월 19일부터 21일까지 테네시주 내쉬빌에서 열리는 스티븐스 연례 투자 컨퍼런스에 참가한다고 발표했습니다. 회사의 회장 겸 CEO인 폴 조셉스는 2024년 11월 19일 화요일 오후 2시(중부 시간) 그랜드 하얏트 내쉬빌에서 진행되는 포럼에 참석할 예정입니다. 또한, Lifecore 경영진은 컨퍼런스 동안 일대일 미팅을 실시할 예정입니다.
Lifecore Biomedical (NASDAQ: LFCR) a annoncé sa participation à la prochaine Conférence Annuelle d'Investissement de Stephens, prévue du 19 au 21 novembre 2024 à Nashville, Tennessee. Le président et PDG de l'entreprise, Paul Josephs, participera à une discussion informelle le mardi 19 novembre 2024 à 14h00, heure centrale, au Grand Hyatt de Nashville. De plus, la direction de Lifecore sera disponible pour des réunions individuelles pendant la conférence.
Lifecore Biomedical (NASDAQ: LFCR) hat seine Teilnahme an der bevorstehenden Stephens Jahreskonferenz für Investitionen bekannt gegeben, die vom 19. bis 21. November 2024 in Nashville, Tennessee, stattfindet. Der Präsident und CEO des Unternehmens, Paul Josephs, wird am Dienstag, den 19. November 2024, um 14:00 Uhr Central Time im Grand Hyatt Nashville an einem Fireside Chat teilnehmen. Darüber hinaus wird das Management von Lifecore während der Konferenz für persönliche Gespräche zur Verfügung stehen.
- None.
- None.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs, the company’s president and chief executive officer, will be a featured speaker in a fireside chat at the upcoming Stephens Annual Investment Conference. The conference is being held November 19-21, 2024, in Nashville, Tennessee.
Details regarding Lifecore’s participation are as follows:
- Stephens Annual Investment Conference
Details: Mr. Josephs will be a featured speaker in a fireside chat and Lifecore management will participate in 1-on-1 meetings
Conference Dates: November 19-21, 2024
Fireside Chat Timing: 2:00 p.m. Central on Tuesday, November 19, 2024
Location: Grand Hyatt Nashville
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
FAQ
When is Lifecore Biomedical (LFCR) presenting at the Stephens Annual Investment Conference 2024?
Where is the Stephens Annual Investment Conference 2024 featuring Lifecore (LFCR) being held?
What type of presentation will Lifecore Biomedical (LFCR) give at the Stephens Conference?
